Comparison of HPV-16 and HPV-18 genotyping and cytological testing as triage testing within human papillomavirus–based screening in Mexico
Importance Triage tests enhance the efficiency cervical cancer screening based on human
papillomavirus (HPV), but the best approach for maximizing programmatic effectiveness is …
papillomavirus (HPV), but the best approach for maximizing programmatic effectiveness is …
[HTML][HTML] Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping
Background Vigilant management of women with high-risk human papillomavirus (hrHPV) is
necessary in cancer screening programs. To this end, we evaluated the performance of S5 …
necessary in cancer screening programs. To this end, we evaluated the performance of S5 …
[HTML][HTML] The burden of 14 hr-HPV genotypes in women attending routine cervical cancer screening in 20 states of Mexico: a cross-sectional study
A Campos-Romero, KS Anderson, A Longatto-Filho… - Scientific reports, 2019 - nature.com
In Mexico, HPV vaccines available immunize against genotypes 16/18 and 16/18/6/11;
however, there is limited surveillance about carcinogenic subtypes in different states of the …
however, there is limited surveillance about carcinogenic subtypes in different states of the …
Eliminating deaths from cervical cancer—report of a panel at the 7th annual Symposium on Global Cancer Research, a satellite meeting at the Consortium of …
A Binagwaho, PJ Garcia, B Gueye… - Journal of Global …, 2019 - ascopubs.org
This is a summary of the presentations addressing approaches and achievements to reach
the goal of eliminating cervical cancer as a global public health problem that were delivered …
the goal of eliminating cervical cancer as a global public health problem that were delivered …
[HTML][HTML] Prevention of cervical cancer in Latin America: Future challenges and opportunities
EL Franco - salud pública de méxico, 2019 - SciELO Public Health
It was not difficult to decide in 1984 that studying cervical cancer epidemiology should be a
key priority when I began my research work at the Sao Paulo Branch of the Ludwig Institute …
key priority when I began my research work at the Sao Paulo Branch of the Ludwig Institute …
Citología en base líquida complementaria en un laboratorio de citología del Programa de Prevención y Control de Cáncer del Cuello Uterino.
P Ortega-González… - Patologia Revista …, 2019 - search.ebscohost.com
ANTECEDENTES: La superioridad de la citología en base líquida sobre la citología cervical
convencional es controvertida; sin embargo, una de sus ventajas es la aplicación de …
convencional es controvertida; sin embargo, una de sus ventajas es la aplicación de …
Prevención y control de neoplasias asociadas a VPH en grupos de alto riesgo de la Ciudad de México: el Estudio Condesa
E Lazcano-Ponce, J Salmerón, A González… - Salud Pública de …, 2019 - medigraphic.com
Objetivo. Evaluar la efectividad de una estrategia combinada de vacunación contra el virus
de papiloma humano (VPH) y tamizaje de VPH de alto riesgo para reducir neoplasias …
de papiloma humano (VPH) y tamizaje de VPH de alto riesgo para reducir neoplasias …
[PDF][PDF] The burden of 14 hr-HPV genotypes in women attending routine cervical cancer screening in 20 states of Mexico: a cross-sectional study
MALR Esparza, DJ Morán-Portela… - hospital.uas.edu.mx
In Mexico, HPV vaccines available immunize against genotypes 16/18 and 16/18/6/11;
however, there is limited surveillance about carcinogenic subtypes in different states of the …
however, there is limited surveillance about carcinogenic subtypes in different states of the …
Uso de la prueba de VPH para la detección de cáncer cervical en México, 2008-2018: estudio de una base de datos nacional
E Hurtado-Salgado, E Ortiz-Panozo… - Salud Pública de …, 2019 - medigraphic.com
Objetivo. Describir los métodos de un estudio que busca comparar el beneficio de la
introducción de la prueba de VPH de alto riesgo como prueba primaria frente a la citología …
introducción de la prueba de VPH de alto riesgo como prueba primaria frente a la citología …
El efecto de un refuerzo de la vacuna tetravalente de VPH después de 51 meses: implicaciones para un esquema de vacunación extendido
E Lazcano-Ponce, M Carnalla-Cortés… - Salud Pública de …, 2019 - medigraphic.com
Objetivo. Evaluar la no inferioridad entre dos diferentes esquemas de vacunación un mes
después de la administración de la tercera dosis. Material y métodos. Se evaluaron los …
después de la administración de la tercera dosis. Material y métodos. Se evaluaron los …